Kymbee Suspension
Product Images NDC 0245-0813

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Kymbee (NDC 0245-0813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Kymbee 01)

Chemical structure of deflazacort, the active ingredient in KYMBEE oral suspension 22.75 mg/mL by Upsher-Smith Laboratories, LLC. The diagram shows the molecular arrangement including several rings, hydroxyl groups, methyl groups, and ketone functional groups characteristic of this corticosteroid compound.*

FDA Label Image

Figure A (Kymbee 02)

An illustration showing the components of KYMBEE oral suspension packaging and dosing supplies. It includes the KYMBEE oral suspension bottle, oral suspension carton, a bottle adapter, an oral dispenser, and a household cup with a spoon. The image labels each item clearly for identification.*

FDA Label Image

Figure B (Kymbee 03)

An instructional illustration showing a hand holding a medicine bottle labeled KYMBEE (deflazacort) oral suspension. Arrows indicate that the bottle should be shaken well before use, emphasizing proper suspension mixing.*

FDA Label Image

Figure C (Kymbee 04)

An instructional diagram showing a hand pressing down and twisting the cap of a bottle, illustrating how to open the bottle.*

FDA Label Image

Figure D (Kymbee 05)

An instructional diagram illustrating how to press down on the ribbed end of a bottle adapter using both thumbs to open or secure the bottle.*

FDA Label Image

Figure E (Kymbee 06)

Illustration of an oral syringe labeled with parts including the plunger and barrel, showing volume measurements marked in milliliters for accurate liquid dosing.*

FDA Label Image

Figure F (Kymbee 07)

An instructional illustration showing a hand holding a plunger, pressing it downward into the opening of a bottle. The image includes a downward arrow emphasizing the motion of inserting the plunger into the bottle, likely demonstrating how to use the dosing syringe for liquid medication.*

FDA Label Image

Figure G (Kymbee 08)

An instructional illustration showing how to measure an oral suspension dose using a syringe. The image highlights measuring the dose from the widest part of the plunger, with a close-up inset focusing on the 0.1 mL mark on the syringe.*

FDA Label Image

Figure H (Kymbee 09)

An instructional illustration showing a hand holding a graduated oral dosing syringe inserted into a bottle for oral suspension. The syringe is being twisted or rotated to draw liquid from the bottle, with volume markings visible on the syringe barrel from 0.1 mL up to 1 mL. An upward arrow above the syringe indicates the direction to pull the plunger to measure the dose.*

FDA Label Image

Figure I (Kymbee 10)

An instructional illustration showing a hand holding a marked oral syringe being placed into a glass of liquid, with a spoon lying next to the glass. The image suggests measuring and administering an oral suspension dose using the syringe.*

FDA Label Image

Figure J (Kymbee 11)

An instructional illustration showing a hand stirring a liquid in a cup with a spoon. The arrow indicates a stirring motion in a clockwise direction. The image appears to demonstrate mixing instructions for an oral suspension.*

FDA Label Image

Figure K (Kymbee 12)

An instructional illustration showing a hand gripping and twisting the cap of a bottle, demonstrating how to open the bottle closure for the KYMBEE deflazacort oral suspension.*

FDA Label Image

Figure L (Kymbee 13)

An instructional illustration showing a hand holding a syringe by the barrel with the other hand pulling the plunger upward. The parts labeled are ''Plunger'' and ''Barrel'' with an arrow indicating upward movement of the plunger, likely demonstrating how to draw medication into the syringe.*

FDA Label Image

Principal Display Panel (13 mL Bottle Carton)

The packaging label for KYMBEE (Deflazacort) Oral Suspension 22.75 mg/mL, a prescription drug by Upsher-Smith Laboratories, LLC. The label indicates a 13 mL oral suspension for oral administration only, including product NDC 0245-0813-13. The carton includes directions for dosage, storage, and contents, such as oral dispensers and a press-in bottle adapter. The label features the Upsher-Smith logo and bar code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.